Niagen Bioscience (NAGE) Prepaid Assets (2011 - 2026)
Niagen Bioscience (NAGE) reported Prepaid Assets of $1.5 million for Q1 2026, down 37.08% year-over-year from $2.4 million in Q1 2025, and up 13.41% quarter-over-quarter from $1.3 million in Q4 2025.
Niagen Bioscience (NAGE) Prepaid Assets (2011 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 14 years of Prepaid Assets data on file, last reported at $1.5 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $1.5 million, down 37.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 million (down 37.08% YoY), and the FY2025 annual result was $1.3 million, down 47.14% from the prior year.
- Prepaid Assets advanced to $1.5 million in Q1 2026 per NAGE's latest filing, from $1.3 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $4.3 million in Q3 2022 and troughed at $1.3 million in Q4 2025.
- A 5-year average of $2.2 million and a median of $2.1 million in 2025 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets jumped 141.71% in 2022, then plunged 48.74% in 2023.
- A 5-year view of Prepaid Assets shows it stood at $3.0 million in 2022, then fell by 17.43% to $2.4 million in 2023, then advanced by 1.31% to $2.5 million in 2024, then plunged by 47.14% to $1.3 million in 2025, then advanced by 13.41% to $1.5 million in 2026.
- Business Quant data shows NAGE's Prepaid Assets at $1.5 million in Q1 2026, $1.3 million in Q4 2025, and $2.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Niagen Bioscience | 280.11 Mn | 213.56 Mn | 19.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.49 Mn |
| Dec 31, 2025 | 1.31 Mn |
| Sep 30, 2025 | 2.03 Mn |
| Jun 30, 2025 | 2.14 Mn |
| Mar 31, 2025 | 2.37 Mn |
| Dec 31, 2024 | 2.48 Mn |
| Sep 30, 2024 | 2.10 Mn |
| Jun 30, 2024 | 2.09 Mn |
| Mar 31, 2024 | 2.31 Mn |
| Dec 31, 2023 | 2.45 Mn |
| Sep 30, 2023 | 2.18 Mn |
| Jun 30, 2023 | 1.89 Mn |
| Mar 31, 2023 | 2.30 Mn |
| Dec 31, 2022 | 2.97 Mn |
| Sep 30, 2022 | 4.26 Mn |
| Jun 30, 2022 | 1.46 Mn |
| Mar 31, 2022 | 1.91 Mn |
| Dec 31, 2021 | 1.86 Mn |
| Sep 30, 2021 | 1.76 Mn |
| Jun 30, 2021 | 972,000.00 |